In hepatocellular carcinoma, glutamine syn- thases 2 (GLS2) acts as a tumor suppressor by promoting ferroptosis through the production of α-ketoglutarate-dependent lipid ROS 71. Here, GLS2 is linked to hepatocellular carcinoma.